CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Open-market buy Director bought 1,212,122 shares at $3.30 ($4,000,003)
- 4/A Open-market sale Chief Accounting Officer sold 1,129 shares at $15.89 ($17,940)
- 4 Open-market sale Chief Accounting Officer sold 2,802 shares at $16.02 ($44,888)
- 4 Insider Changes in Ownership
- 4 Open-market buy Director bought 20,000 shares at an average $13.21 ($264,289)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Accounting Officer gave up 759 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 32,005,260 shares at $12.25 ($392,064,435)
- 4 Grant or award Director acquired 17,482 shares (grant or award)
- 4 Grant or award Director acquired 17,482 shares (grant or award)
- 4 Grant or award Director acquired 17,482 shares (grant or award)
- 4 Grant or award Director acquired 17,482 shares (grant or award)
- 4 Grant or award Director acquired 17,482 shares (grant or award)
- 4 Grant or award Director acquired 17,482 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Grant or award Chief Accounting Officer acquired 10,305 shares (grant or award)
- 4 Grant or award Director acquired 1,612 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 4,285,935 shares at $3.25 ($13,929,289)
- 3 Insider Initial Statement of Ownership
Page 6 of 39 · 776 filings